Regenerative medicine in the field of pain medicine: Prolotherapy, platelet-rich plasma therapy, and stem cell therapy-Theory and evidence

Techniques in Regional Anesthesia and Pain Management

Volumn 15, Issue 2, 2011, Pages 74-80

  DeChellis, David M ^a   Cortazzo, Megan Helen ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Platelet rich plasma; Prolotherapy; Regenerative medicine; Stem cell therapy

Indexed keywords

CHEMOTACTIC FACTOR; GLYCEROL; MORRHUATE SODIUM; OSMOTIC AGENT; ZINC SULFATE;

ACHILLES TENDINITIS; ARTICLE; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CENTRIFUGATION; CULTURE MEDIUM; FIBROBLAST; HUMAN; IMMUNE SYSTEM; LIGAMENT INJURY; LOW BACK PAIN; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCULOSKELETAL DISEASE; NONHUMAN; OSTEOARTHRITIS; PAIN; PAIN ASSESSMENT; PHYSICIAN; PLANTAR FASCIITIS; PLASMA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANGE OF MOTION; REGENERATIVE MEDICINE; STANDARDIZATION; STEM CELL TRANSPLANTATION; TENDON INJURY; THROMBOCYTE RICH PLASMA; TISSUE REGENERATION; WOUND HEALING;

EID: 80051934630     PISSN: 1084208X     EISSN: 15584534     Source Type: Journal    
DOI: 10.1053/j.trap.2011.05.002     Document Type: Article

References (120)

1. Woolf A.D., Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organization 2003, 81:646-656.
2. Ljungqvist A., Schwellnus M.P., Bachl N., et al. International Olympic Committee consensus statement: molecular basis of connective tissue and muscle injuries in sport. Clin Sports Med 2008, 27:231-239.
3. Richardson S.M., Hoyland J.A., Mobasheri R., et al. Mesenchymal stem cells in regenerative medicine: opportunities and challenges for articular cartilage and intervertebral disc tissue engineering. J Cell Physiol 2010, 222:23-32.
4. Centeno C.J., Busse D., Kisiday J., et al. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician 2008, 11:343-353.
5. Hackett G.S. Ligament and Tendon Relaxation Treated by Prolotherapy (ed 5) 1991, Thomas Publisher, Springfield, IL. C. Charles (Ed.).
6. Linetsky F., Trescot A., Manchikanti L. Interventional Techniques in Chronic Non-Spinal Pain: Regenerative Injection Therapy 2009, 87-98. ASIPP Publishing Group.
7. Mooney V. Prolotherapy at the fringe of medical care, or is it the frontier?. Spine J 2003, 3:253-254.
8. Gedney E.H. Hypermobile joint: a preliminary report. Osteopath Prof 1937, 4:30-31.
9. Linetsky S.-H. Prolotherapy. Pain Medicine and Management: Just the Facts 2004, 318-324. McGraw-Hill Companies, New York. M. Wallace, P. Staats (Eds.).
10. Linetsky F., Botwin K., Torres F., et al. Position paper of the Florida Academy of Pain Medicine on regenerative injection therapy: effectiveness and appropriate usage. Pain Clin 2002, 4:38-45.
11. Reeves K.D., Hassanein K. Randomized, prospective, placebo-controlled double-blind study of dextrose prolotherapy for osteoarthritic thumb and finger (DIP, PIP, and trapeziometacarpal) joints: evidence of clinical efficacy. J Altern Complement Med 2000, 6:311-320.
12. Wilkinson H.A. Injection therapy for enthesopathies causing axial spine pain and the "failed back syndrome": A single blinded, randomized and cross-over study. Pain Physician 2005, 8:167-173.
13. Rabago D., Slattengren A., Zgierska A. Prolotherapy in primary care practice. Prim Care 2010, 37:65-80.
14. Banks A.R. A rationale for prolotherapy. J Orthop Med 1991, 13:54-59.
15. Rabago D., Best T.M., Beamsley M., et al. A systematic review of prolotherapy for chronic musculoskeletal pain. Clin J Sport Med 2005, 15:376-380.
16. Yelland M.J., Del Mar C., Pirozzo S., et al. Prolotherapy injections for chronic low back pain: a systematic review. Spine 2004, 29:2126-2133.
17. Dagenais S., Mayer J., Haldeman S., et al. Evidence-informed management of chronic low back pain with prolotherapy. Spine J 2008, 8:203-212.
18. Linetsky F., Saberski L., Dubin J.A., et al. Prolotherapy injections, saline injections, and exercises for chronic low-back pain: a randomized study. Spine 2004, 29:1840-1841.
19. Maynard J.A., Pedrini V.A., Pedrini-Mille A., et al. Morphological and biochemical effects of sodium morrhuate on tendons. J Orthop Med 1991, 13:54-59.
20. Aneja A., Karas S.G., Weinhold P.S., et al. Suture plication, thermal shrinkage, and sclerosing agents: effects on rat patellar tendon length and biomechanical strength. Am J Sports Med 2005, 33:1729-1734.
21. Liu Y.K., Tipton C.M., Matthes R.D., et al. An in situ study of the influence of a sclerosing solution in rabbit medial collateral ligaments and its junction strength. Connect Tissue Res 1983, 11:95-102.
22. Jensen K.T., Rabago D.P., Best T.M., et al. Response of knee ligaments to prolotherapy in a rat injury model. Am J Sports Med 2008, 36:1347-1357.
23. Reeves K.D., Hassanein K.M. Long-term effects of dextrose prolotherapy for anterior cruciate ligament laxity. Altern Ther Health Med 2003, 9:58-62.
24. Grote W., Delucia R., Waxman R., et al. Repair of complete anterior cruciate tear using prolotherapy: a case report. Int. J Musculoskelet Med 2009, 31:159-165.
25. Lazzara M. The non-surgical repair of a complete Achilles tendon rupture by prolotherapy: biological reconstruction. A case report. J Orthop Med 2005, 27:128-132.
26. Lyftogt J. Subcutaneous prolotherapy treatment of refractory knee, shoulder and lateral elbow pain. Australas J Musculoskelet Med 2007, 12:110-112.
27. Scarpone M., Rabago D.P., Zgierska A., et al. The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clin J Sport Med 2008, 18:48-54.
28. Ryan M., Wong A., Taunton J. Favorable outcomes after sonographically guided intratendinous injection of hyperosmolar dextrose for chronic insertional and midportion Achilles tendinosis. AJR Am J Roentgenol 2010, 194:1047-1053.
29. Maxwell N.J., Ryan M.B., Taunton J.E., et al. Sonographically guided intratendinous injection of hyperosmolar dextrose to treat chronic tendinosis of the Achilles tendon: a pilot study. AJR Am J Roentgenol 2007, 189:W215-W220.
30. Khan S.A., Kumar A., Varshney M.K., et al. Dextrose prolotherapy for recalcitrant coccygodynia. J Orthop Surg (Hong Kong) 2008, 16:27-29.
31. Topol G.A., Reeves K.D. Regenerative injection of elite athletes with career-altering chronic groin pain who fail conservative treatment: a consecutive case series. Am J Phys Med Rehabil 2008, 87:890-902.
32. Ryan M.B., Wong A.D., Gillies J.H., et al. Sonographically guided intratendinous injections of hyperosmolar dextrose/lidocaine: a pilot study for the treatment of chronic plantar fasciitis. Br J Sports Med 2009, 43:303-306.
33. Reeves K., Hassanein K. Randomized prospective double-blind placebo-controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity. Altern Ther Health Med 6:68-74 2000, 77-80.
34. Kim W.M., Lee H.G., Jeong C.W., et al. A randomized controlled trial of intra-articular prolotherapy versus steroid injection for sacroiliac joint pain. J Altern Complement Med 2010, 16:1285-1290.
35. Centeno C.J., Elliott J., Elkins W.L., et al. Fluoroscopically guided cervical prolotherapy for instability with blinded pre and post radiographic reading. Pain Physician 2005, 8:67-72.
36. Hooper R.A., Frizzell J.B., Faris P. Case series on chronic whiplash related neck pain treated with intraarticular zygapophysial joint regeneration injection therapy. Pain Physician 2007, 10:313-318.
37. Matthews J.A., Mills S.B., Jenkins V.M., et al. Back pain and sciatica: controlled trials of manipulation, traction, sclerosant and epidural injections. Br J Rheumatol 1987, 26:416-423.
38. Ongley M.J., Klein R.G., Dorman T.A., et al. A new approach to the treatment of chronic low back pain. Lancet 1987, 2:143-146.
39. Klein R.G., Eek B.C., DeLong W.B., et al. A randomized double-blind trial of dextrose-glycerine-phenol injections for chronic, low back pain. J Spinal Disord 1993, 6:23-33.
40. Dechow E., Davies R.K., Carr A.J., et al. A randomized, double-blind, placebo-controlled trial of sclerosing injections in patients with chronic low back pain. Rheumatology (Oxford) 1999, 38:1255-1259.
41. Dagenais S., Yelland M.J., Del Mar C., et al. Prolotherapy injections for chronic low-back pain. Cochrane Database Syst Rev 2007, 2:CD004059.
42. Reeves K.D., Klein R.G., DeLong W.B., et al. Prolotherapy injections, saline injections, and exercises for chronic low-back pain: a randomized study. Spine 2004, 29:1839-1840.
43. Miller M.R., Matthews R.S., Reeves K.D. Treatment of painful advanced internal lumbar disc derangement with intradiscal injection of hypertonic dextrose. Pain Physician 2006, 9:115-121.
44. Dagenais S., Ogunseitan O., Haldeman S., et al. Side effects and adverse events related to intraligamentous injection of sclerosing solutions (prolotherapy) for back and neck pain: a survey of practitioners. Arch Phys Med Rehabil 2006, 87:909-913.
45. Hernandez D. Saito's on the cutting edge October 03, 2008, Los Angeles Times.
46. Schwarz A. A promising treatment for athletes, in blood February 17, 2009, The New York Times, Page A1.
47. Ferrari M., Zia S., Valbonesi M., et al. A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery. Int J Artif Organs 1987, 10:47-50.
48. Marx R.E. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004, 62:489-496.
49. Engerbretsen L., Steffen K., Alsousou J., et al. IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med 2010, 44:1072-1081.
50. Foster T.E., Puskas B.L., Mandelbaum B.R., et al. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 2009, 37:2259-2272.
51. Anitua E., Andia I., Ardanza B., et al. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004, 91:4-15.
52. Hall M.P., Band P.A., Meislin R.J., et al. Platelet-rich plasma: current concepts and applications in sports medicine. J Am Acad Orthop Surg 2009, 17:602-608.
53. Sampson S., Gerhardt M., Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 2008, 1:165-174.
54. De Mos M., van der Windt A.E., Jahr H., et al. Can platelet-rich plasma enhance tendon repair?. A cell culture study. Am J Sports Med 2008, 36:1171-1178.
55. Haynesworth SE, Kadiyala S, Liang LN, et al: Mitogenic stimulation of human mesenchymal stem cells by platelet release suggest a mechanism for enhancement of bone repair by platelet concentrates: Presented at the 48th Meeting of the Orthopedic Research Society, Boston, MA, 2002.
56. Kazemi M., Azma K., Tavana B., et al. Autologous blood versus corticosteroid local injection in the short-term treatment of lateral elbow tendinopathy: a randomized clinical trial of efficacy. Am J Phys Med Rehabil 2010, 89:660-667.
57. Castillo T.N., Pouliot M.A., Kim H.J., et al. Comparison of growth factors and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med 2011, 39:66-71.
58. Fufa D., Shealy B., Jacobson M., et al. Activation of platelet-rich plasma using soluble type I collagen. J Oral Maxillofac Surg 2008, 66:684-690.
59. Harmon K.G. Muscle injuries and PRP: what does the science say?. Br J Sports Med 2010, 44:616-617.
60. Aspenberg P., Virchenko O. Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthop Scand 2004, 75:93-99.
61. Kajikawa Y., Morihara T., Sakamoto H., et al. Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing. J Cell Physiol 2008, 215:837-845.
62. Ishida K., Kuroda R., Miwa M., et al. The regenerative effects of platelet-rich plasma on meniscal cells in vitro and its in vivo application with biodegradable gelatin hydrogel. Tissue Eng 2007, 13:1103-1112.
63. Murray M.M., Spindler K.P., Ballard P., et al. Enhanced histologic repair in a central wound in the anterior cruciate ligament with a collagen-platelet-rich plasma scaffold. J Orthop Res 2007, 25:1007-1017.
64. Akeda K., An H.S., Okuma M., et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage 2006, 14:1272-1280.
65. Saito M., Takahashi K.A., Arai Y., et al. Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee. Clin Exp Rheumatol 2009, 27:201-207.
66. Qi Y.Y., Chen X., Jiang Y.Z., et al. Local delivery of autologous platelet in collagen matrix simulated in situ articular cartilage repair. Cell Transplant 2009, 18:1161-1169.
67. Sun Y., Feng Y., Zhang C.Q., et al. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop 2010, 34:589-597.
68. Farrag T.Y., Lehar M., Verhaegen P., et al. Effect of platelet rich plasma and fibrin sealant on facial nerve regeneration in a rat model. Laryngoscope 2007, 117:157-165.
69. Sariguney Y., Yavuzer R., Elmas C., et al. Effect of platelet-rich plasma on peripheral nerve regeneration. J Reconstr Microsurg 2008, 24:159-167.
70. Akeda K., An H.S., Pichika R., et al. Platelet-rich plasma (PRP) stimulates the extracellular matrix metabolism of porcine nucleus pulposus and anulus fibrosus cells cultured in alginate beads. Spine 2006, 31:959-966.
71. Nagae M., Ikeda T., Mikami Y., et al. Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres. Tissue Eng 2007, 13:147-158.
72. Wright-Carpenter T., Klein P., Schäferhoff P., et al. Treatment of muscle injuries by local administration of autologous conditioned serum: A pilot study on sportsmen with muscle strains. Int J Sports Med 2004, 25:588-593.
73. Hamilton B., Knez W., Eirale C., et al. Platelet enriched plasma for acute muscle injury. Acta Orthop Belg 2010, 76:443-448.
74. Sánchez M., Anitua E., Orive G., et al. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med 2009, 39:345-354.
75. Mei-Dan O., Lippi G., Sanchez M., et al. Autologous platelet-rich plasma: a revolution in soft tissue sports injury management?. Phys. Sports Med 2010, 38:127-135.
76. Barrett S., Erredge S.E. Growth factors for chronic plantar fasciitis?. Podiatry Today 2004, 17:36-42.
77. Baker J.F., Walsh P.M., Byrne D.P., et al. In vitro assessment of human chondrocyte viability after treatment with local anaesthetic, magnesium sulphate or normal saline. Knee Surg Sports Traumatol Arthrosc 2011, 19:1043-1046.
78. Raynauld J.P., Buckland-Wright C., Ward R., et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2003, 8:370-377.
79. Papacrhistou G., Anagnostou S., Katsorhis T. The effect of intraarticular hydrocortisone injection on the articular cartilage of rabbits. Acta Ortho Scand 1997, 275(suppl):132-134.
80. Harvey W.F., Hunter D.J. The role of analgesics and intra-articular injections in disease management. Rheum Dis Clin North Am 2008, 34:777-788.
81. Miyazaki Y., Tsukazaki T., Hirota Y., et al. Dexamethasone inhibition of TGF beta-induced cell growth and type II collagen mRNA expression through ERK-integrated AP-1 activity in cultured rat articular chondrocytes. Osteoarthritis Cartilage 2000, 8:378-385.
82. Kon E., Buda R., Filardo G., et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 2010, 18:472-479.
83. Sampson S., Reed M., Silvers H., et al. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: A pilot study. Am J Phys Med Rehabil 2010, 89:961-969.
84. Filardo G., Kon E., Buda R., et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2011, 19:528-535.
85. Kon E., Filardo G., Delcogliano M., et al. Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee. Injury 2009, 40:598-603.
86. Mirsha A., Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 2006, 34:1774-1778.
87. Gaweda K., Tarczynska M., Krzyzanowski W. Treatment of Achilles tendinopathy with platelet-rich plasma. Int J Sports Med 2010, 31:577-583.
88. Peerbooms J.C., Sluimer J., Bruijn D.J., et al. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med 2010, 38:255-262.
89. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
90. Fong E.L., Chan C.K., Goodman S.B. Stem cell homing in musculoskeletal injury. Biomaterials 2011, 32:395-409.
91. Grigolo B., Lisignoli G., Desando G., et al. Osteoarthritis treated with mesenchymal stem cells on hyaluronan-based scaffold in rabbit. Tissue Eng C Methods 2009, 15:647-658.
92. Prockop D.J., Gregory C.A., Spees J.L. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci USA 2003, 100(suppl 1):11917-11923.
93. Woodbury D., Schwarz E.J., Prockop D.J., et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000, 61:364-370.
94. Meliga E., Strem B.M., Duckers H.J., et al. Adipose-derived cells. Cell Transplant 2007, 16:963-970.
95. Minguell J.J., Conget P., Erices A. Biology and clinical utilization of mesenchymal progenitor cells. Braz J Med Biol Res 2000, 33:881-887.
96. Friedenstein A.J., Gorskaja J.F., Kulagina N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976, 4:267-274.
97. Nelson L., Fairclough J., Archer C.W. Use of stem cells in the biological repair of articular cartilage. Expert Opin Biol Ther 2010, 10:43-55.
98. Lee R.H., Kim B., Choi I., et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004, 14:311-324.
99. Gimble J.M., Katz A.J., Bunnell B.A. Adipose-derived stem cells for regenerative medicine. Circ Res 2007, 100:1249-1260.
100. Barry F.P., Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004, 36:568-584.
101. Im G.I., Shin Y.W., Lee K.B. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells?. Osteoarthritis Cartilage 2005, 13:845-853.
102. De Ugarte D.A., Morizono K., Elbarbary A., et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003, 74:101-109.
103. Dominici M., Le Blanc K., Mueller I., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cryotherapy 2006, 8:315-317.
104. Mansilla E., Marín G.H., Drago H., et al. Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: New evidence for their use in regenerative medicine. Transplant Proc 2006, 38:967-969.
105. Ramírez M., Lucia A., Gómez-Gallego F., et al. Mobilisation of mesenchymal cells into blood in response to skeletal muscle injury. Br J Sports Med 2006, 40:719-722.
106. Zannettino A.C., Paton S., Arthur A., et al. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol 2008, 214:413-421.
107. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007, 213:341-347.
108. Hernigou P., Poignard A., Beaujean F., et al. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 2005, 87:1430-1437.
109. Yoshikawa T., Ueda Y., Miyazaki K., et al. Disc regeneration therapy using marrow mesenchymal cell transplantation: a report of two case studies. Spine 2010, 35:E475-E480.
110. LaBarge M.A., Blau H.M. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 2002, 111:589-601.
111. Chong A.K., Ang A.D., Goh J.C., et al. Bone marrow-derived mesenchymal stem cells influence early tendon-healing in a rabbit Achilles tendon model. J Bone Joint Surg Am 2007, 89:74-81.
112. Mirsha A., Tummala P., King A., et al. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng C Methods 2009, 15:431-435.
113. Shapiro F., Koide S., Glimcher M.J. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am 1993, 75:532-553.
114. Murphy J.M., Dixon K., Beck S., et al. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum 2002, 46:704-713.
115. Coleman C.M., Curtin C., Barry F.P., et al. Mesenchymal stem cells and osteoarthritis: remedy or accomplice?. Hum Gene Ther 2010, 21:1239-1250.
116. Murphy J.M., Fink D.J., Hunziker E.B., et al. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003, 48:3464-3474.
117. Lee K.B., Hui J.H., Song I.C., et al. Injectable mesenchymal stem cell therapy for large cartilage defects-a porcine model. Stem Cells 2007, 25:2964-2971.
118. Henriksson H., Thornemo M., Karlsson C., et al. Identification of cell proliferation zones, progenitor cells and a potential stem cell niche in the intervertebral disc region: a study in four species. Spine 2009, 34:2278-2287.
119. Wang Y.T., Wu X.T., Wang F. Regeneration potential and mechanism of bone marrow mesenchymal stem cell transplantation for treating intervertebral disc degeneration. J Orthop Sci 2010, 15:707-719.
120. Leung V.Y., Chan D., Cheung K.M. Regeneration of intervertebral disc by mesenchymal stem cells: potentials, limitations, and future direction. Eur Spine J 2006, 15(suppl 3):S406-S413.